The Mito Foundation held a digital symposium on Thursday 17 September, as part of World Mitochondrial Disease Week (formerly Global Mitochondrial Disease Awareness Week). The Symposium gathered leading local and international mitochondrial disease (mito) experts to explore the latest research developments and their implications on future treatments and diagnosis of mito.
The Symposium's theme was "Gene Therapies and the Promise for Mitochondrial Disease".
Curated by two leading Australian mitochondrial disease experts, Prof Mike Ryan and Prof David Thorburn, the Symposium explored the latest in gene therapies and the implications for future diagnosis and treatments.
We were excited to have an incredible line-up of expert speakers from around the globe:
- Prof Ian Alexander, Children's Medical Research Institute (Australia)
- Prof Carlos Moraes, Miller School of Medicine, University of Miami (USA)
- Prof Vamsi Mootha, Howard Hughes Medical Institute & Harvard Medical School (USA)
- Dr Beverly Mok, Harvard University (USA)
Symposium Resources and Recordings
Please use the links below to access the relevant resource:
- Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity (article) - Featuring work done by Prof Ian Alexander
- Myopathy reversion in mice after restauration of mitochondrial complex I (article) - Featuring work done by Prof Carlos Moraes
- Sean Murray - Mito Foundation Update (recording)
- New molecular tool precisely edits mitochondrial DNA (article) - Featuring work done by Beverly Mok